单位自行采购信息公开
Renal outcomes with dolutegravir plus lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in ART-naive adults with HIV

2026/05/18 16:08:44

Renal outcomes with dolutegravir plus lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in ART-naive adults with HIV出版服务

现就深圳大学自行采购出版服务公开以下信息:

(1)出版的论名称:Renal outcomes with dolutegravir plus lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in ART-naive adults with HIV

(2)单位及作者:医学部 刘甲野(其他)

3)合同金额:36478.28

4)供应商名称:Lippincott Williams and Wilkins Ltd.

5)成时间:2026515



深圳大学招投标管理中心

2026518



手机扫码查看